Geneva Capital Management LLC Bio Techne Corp Transaction History

Geneva Capital Management LLC

$5.88 Billion
Q3 2024

A detailed history of Geneva Capital Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 1,104,310 shares of TECH stock, worth $80.8 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

1,104,310

Previous 1,087,196 1.57%

Holding current value

$80.8 Million

Previous $77.9 Million 13.28%

% of portfolio

1.5%

Previous 1.43%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$70.96 - $82.35 $1.21 Million - $1.41 Million	17,114 Added 1.57%	1,104,310 $88.2 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $67.5 Million - $91.5 Million	1,087,196 New	1,087,196 $77.9 Million
Q1 2024 May 03, 2024	BUY	$65.98 - $77.09 $49,946 - $58,357	757 Added 0.07%	1,080,013 $76 Million
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $492,481 - $729,166	9,322 Added 0.87%	1,079,256 $83.3 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $106,884 - $141,551	-1,583 Reduced 0.15%	1,069,934 $72.8 Million
Q2 2023 Aug 01, 2023	BUY	$73.76 - $85.98 $92,937 - $108,334	1,260 Added 0.12%	1,071,517 $87.5 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $770,416 - $931,771	10,757 Added 1.02%	1,070,257 $79.4 Million
Q4 2022 Feb 07, 2023	BUY	$80.67 - $352.29 $64 Million - $279 Million	793,107 Added 297.72%	1,059,500 $87.8 Million
Q3 2022 Nov 02, 2022	BUY	$282.54 - $391.85 $75.3 Million - $104 Million	266,393 New	266,393 $75.7 Million
Q2 2022 Aug 02, 2022	SELL	$322.67 - $449.65 $475,938 - $663,233	-1,475 Reduced 0.57%	256,177 $88.8 Million
Q1 2022 May 02, 2022	SELL	$353.85 - $487.79 $274,233 - $378,037	-775 Reduced 0.3%	257,652 $112 Million
Q4 2021 Feb 02, 2022	SELL	$456.15 - $525.06 $2.68 Million - $3.09 Million	-5,880 Reduced 2.22%	258,427 $134 Million
Q3 2021 Nov 08, 2021	SELL	$444.87 - $538.88 $39.4 Million - $47.8 Million	-88,674 Reduced 25.12%	264,307 $128 Million
Q2 2021 Aug 11, 2021	SELL	$387.35 - $450.26 $2.11 Million - $2.45 Million	-5,443 Reduced 1.52%	352,981 $159 Million
Q1 2021 May 03, 2021	SELL	$314.62 - $411.0 $14 Million - $18.3 Million	-44,534 Reduced 11.05%	358,424 $137 Million
Q4 2020 Feb 02, 2021	BUY	$246.9 - $321.87 $2.86 Million - $3.73 Million	11,573 Added 2.96%	402,958 $128 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $2.06 Million - $2.51 Million	8,873 Added 2.32%	391,385 $97 Million
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $1.95 Million - $2.94 Million	10,499 Added 2.82%	382,512 $101 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $60 Million - $82.4 Million	372,013 New	372,013 $70.5 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Bio Techne Corp Transaction History